Chat with us, powered by LiveChat


News from the healing community.

Looking for Natural Alternative? Here’s Why You Should Use CBD Oil

CBD, also known as cannabidiol, is one of the many chemical compounds found in the hemp plant. There are two major types of CBD, which are CBD isolate and full-spectrum CBD oil. The two differ in composition as CBD isolate is wholly made from cannabidiol, while full-spectrum CBD oil is acquired from the non-psychoactive threads of the marijuana plant.

Full-spectrum CBD can be referred to as the entire plant CBD since it is acquired together with other chemical components of cannabis, including terpenes, vitamins, and cannabinoids. Tetrahydrocannabinol (THC) is the chemical element in the cannabis plant that causes hallucinations. THC free CBD oil can be consumed in several ways, such as CBD tinctures and CBD vape pens.

It also has little impact on your mental health, cognitive processes, and mood since it is derived from components that are high in cannabidiol. There is no age limit to people who can use the THC free CBD oil, and it is also available in multiple states. This article seeks to highlight the various benefits linked with the use of CBD oil.

Reduces Inflammation and Pain

In previous years, the hemp plant was highly sought-after to cure chronic pain. Currently, researchers have traced, isolated, and studied the actual parts of the cannabis plant attributed to pain alleviation. Research conducted in 2018 indicated that THC free CBD oil, as well as other cannabinoids, could reduce various kinds of pain.

Through impacting a neurotransmitter known as endocannabinoid, the THC free CBD oil can relieve pain. The endocannabinoid is found in the brain and deals with controlling reactions to appetite, pain, and sleep. Since it can inhibit oxidation, CBD oil for pain is crucial in general physical wellness.

THC Free CBD Oil Decreases Anxiety and Depression

Anxiety and depression rank highly among the mental health conditions that affect society. Individuals with such psychological problems are going for the alternative natural remedy as opposed to drugs that are accessible over the counter. With the utilization of CBD oil for anxiety, positively influences serotonin which is a neurotransmitter in control of social conduct and mood.

Most people who battle with anxiety or depression prefer CBD oil as it has zero adverse effects. Research has proven that THC free CBD oil helps alleviate anguish, insomnia, PTSD, and conditions of social anxiety.

Helps in the Fight Against Cancer

The latest findings indicate that THC free hemp oil can aid in fighting against the multiplication of cancer cells. It reduces the growth of cancer cells and stops the relocation of these cells to healthy parts of the body. With the known CBD impact on endocannabinoid, which creates a state of balance in the biological system, CBD can assist with anti-cancer therapies.

Cancer patients who undergo chemotherapy can benefit from CBD oil as it alleviates the pain incurred during treatment. CBD is also known to lessen vomiting and nausea, which are common adverse effects of chemotherapy. When it comes to treating cancer, CBD oil bodes well as it has minimal toxicity, non-intrusive, and non-hallucinogenic properties.

CBD for Patients With Memory Loss

Alzheimer patients can benefit from CBD as it reduces the progression of social recognition disorders. Full-spectrum CBD oil zero THC is helpful to people on the onset of Alzheimer’s as it reserves their capability of identifying familiar faces. Recent studies indicate that THC free CBD oil can alter cognitive disorders and contains neuroprotective characteristics.

The study is the first of its kind to prove that full-spectrum CBD oil can be used by Alzheimer patients to curb social isolation and facial recognition disorders. Many treatment options decrease the effects of the conditions, but this is the first to reduce the physical progression of Alzheimer’s.

THC free CBD oil has proven effective in the treatment of many diseases. CBD oil offers an excellent natural remedy to multiple health disorders, and in the coming years, more uses will be practiced in the real world.

Marijuana legalization bill passes historic House committee vote

This article was shared from: 

The bill would effectively legalize marijuana at the federal level, while allowing states to draft their own laws. 

  • The bill aims to decriminalize marijuana and expunge federal convictions, among other provisions.
  • To become law, it still has to pass through the Republican-controlled Senate.
  • A majority of Americans support legalizing recreational marijuana, according to a recent Pew survey.

A bill that would decriminalize and deschedule marijuana at the federal level passed 24 to 10 in the House Judiciary Committee, marking the first time a Congressional body has approved legalization-related legislation.

The bill — called the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2019 — aims to:

  • Remove marijuana as a federally controlled substance
  • Expunge federal convictions and arrests for marijuana
  • Create a Cannabis Justice Office that would levy a 5% tax on marijuana sales in states that have already legalized the drug
  • Allocate federal resources to communities that have been negatively impacted by the war on drugs
  • Allow the Small Business Administration to issue loans and grants to marijuana-related businesses

Under MORE, states would still be able to decide whether or not to legalize marijuana, or expunge convictions. To become federal law, the MORE Act would have to pass through other House committees, and it would then face the more difficult task of passing through the Republican-controlled Senate, where conservative leadership could choose not to consider the bill. Of the 24 House Judiciary Committee members who approved MORE, two were Republican: Matt Gaetz of Florida and Tom McClintock of California.

The More Act was introduced by Rep. Jerrold Nadler, D-N.Y., and co-sponsored by more than 50 lawmakers.

“These steps are long overdue,” Nadler said in a statement. “For far too long, we have treated marijuana as a criminal justice problem instead of a matter of personal choice and public health. Whatever one’s views on the use of marijuana for recreational or medicinal purposes, arresting, prosecuting, and incarcerating users at the federal level is unwise and unjust.”

Most Americans seem to agree. In a November 2019 survey from the Pew Research Center, more than half of U.S. adults said medical and recreational marijuana should be legal, with only 8 percent of adults saying it should be illegal in all forms.

Currently, 11 states and the District of Columbia have legalized both recreational and medicinal marijuana, while medicinal marijuana is available in 33 states and the District of Columbia, Guam, Puerto Rico and the U.S. Virgin Islands, according to the National Conference of State Legislatures.

A (mostly) partisan issue

Despite public support, it seems many Republicans are at least skeptical, if not outright opposed, to pursuing marijuana legislation.

“I don’t think a majority of the Republicans will support this bill,” Colorado Republican and Committee member Ken Buck, said Wednesday. “It is even less likely that the Senate would take it up. Therefore, I would just suggest that we deal with other bills that we can get a much larger bipartisan support from.”

Meanwhile, almost all of the Democratic 2020 presidential candidates support marijuana legalization, except former Vice President Joe Biden. During the primary debate on Wednesday, Biden opposed legalizing marijuana at the federal level, suggesting more scientific research is needed to see whether it’s a “gateway drug.” The Centers for Disease Control and Prevention agrees that more research is needed, but notes that the “majority of people who use marijuana do not go on to use other, “harder” substances.”

The costs of prohibition

Even if there are social costs to legalization, prohibition isn’t free. The American Civil Liberties Union estimates there were 8.2 million marijuana-related arrests in the U.S. between 2001 and 2010, with police spending about $4,390 per arrest and $73,170 per felony conviction. For cases that didn’t lead to conviction, individuals might have spent thousands of dollars on legal services or fines related to the charge.

The MOVE Act might not become law, but many legalization advocates see it as a promising sign in the broader fight against the war on drugs.

“Today’s vote marks a turning point for federal cannabis policy, and is truly a sign that prohibition’s days are numbered,” Aaron Smith, executive director of the National Cannabis Industry Association (NCIA), told Forbes.

Investigation: Mislabeled CBD Products

This article was ripped from the headlines and shared from:

Independent lab tests have revealed that many companies exaggerate the amount of CBD in their products. Some also falsely claim that their products are THC-free. Now, customers are suing for their money back.


Lawsuits are being filed over cannabidiol products that allegedly contain less CBD than advertised. According to one case, independent lab tests commissioned by NBC investigators found that the issue is seemingly widespread in the industry. 

“20 of [the 35 samples tested] had less than half of the amount of CBD advertised on the label” and “[s]ome samples had no CBD at all.”

The cases argue that companies fraudulently charge premiums based on “fictitious CBD quantity claims.” Customers who overpaid for products that weren’t what they seemed to be are looking to get their money back.


Take Action

If you purchased any of the products under investigation, join other CBD users taking action. Attorneys believe you’re owed money back. These lawsuits could also help put an end to this industry-wide problem. To learn more about your legal options and how to get involved, click here.  

Remember, it doesn’t cost anything to contact us or speak to the lawyers we work with, and you aren’t obligated to take further legal steps if you don’t want to.

Who is is a group of online professionals who are committed to exposing corporate wrongdoing and giving consumers the tools they need to fight back. We’ve been reporting on the legal space for nearly a decade and have built relationships with class action and mass tort attorneys across the country.

US Patent 6630507 – The US Government’s Cannabis Patent

Marijuana has been a Schedule I drug in the United States since the Controlled Substances Act of 1970. Richard Nixon and his ‘war on drugs’ didn’t care about loads of evidence showing all the medicinal uses of cannabis; he simply wanted marijuana banned. In fact, it was the National Commission on Marihuana and Drug Abuse that Nixon himself hired to prove the dangers of cannabis who ended up recommending cannabis instead be decriminalized based on the results of their findings. Unfortunately, the reasons for the banning of marijuana were not necessarily fair or logical, but here we are in 2019, and it is still a highly controlled substance. 

Throughout the years, as marijuana has been up for rescheduling again and again, the Drug Enforcement Administration (DEA) continues to refuse regardless of studies showing marijuana’s numerous benefits. The DEA’s most recent refusal to reschedule marijuana happened in 2016. For the record, a Schedule I drug is one that has ‘no current accepted medicinal value in the United States.’ That’s where we’re at with marijuana currently, which seems ludicrous, especially considering that opioids have created an unprecedented crisis in the country for all the harm they cause. Still opioids are more useful than marijuana in the eyes of the government. 

All this isn’t really news. We know the national government has long been ignoring the benefits of marijuana that countless studies have shown. What is curious, however, is that, despite keeping marijuana a Schedule I drug, the US Department of Health and Human Services (HHS) has a patent on certain parts of the marijuana plant. Patent no. 6,630,507 covers:

the potential use of non-psychoactive cannabinoids to protect the brain from damage or degeneration caused by certain diseases, such as cirrhosis.

The patent also covers cannabinoids that are useful in treating things like Alzheimer’s, Parkinson’s, and HIV dementia. 

How can it be that the government keeps cannabis a Schedule I drug while at the same time having a patent on the plant for its medicinal uses? Is this utter hypocrisy, or are we missing something?

To be clear, the HHS does not have a patent on marijuana as a whole. The patent covers only parts of the plant, including the natural and synthetic non-psychoactive cannabinoids, including cannabidiol (CBD). CBD, as most cannabis-friendly folks know at this point, does not get anyone high. It is for this reason it seems there is some kind of loophole that has permitted patent no. 6,630,507 to go through.

How The US Government First Got a Patent on Cannabis

Back in 1999, three scientists from the National Institute of Mental Health (NIMH), Hampson, Axelrod, and Grimaldi, filed for patent no. 6,630,507. In 2003, the HHS gave them their patent. NIMH is part of the larger government agency, the National Institute on Drug Abuse (NIDA). NIDA is notorious for their anti-marijuana stance, publishing lots of studies that show marijuana is very bad. 

Perhaps the fact that there are more than 20,000 studies that have shown marijuana’s positive medical effects is what led to NIDA granting this marijuana patent, especially since it only covers CBD, the non-psychoactive elements of the plant, for treating neurological conditions. Within the patent, it states the scientists discovered that there are antioxidant properties in CBD. It also states that any cannabinoid that acts through receptors such as THC is not covered. Still, issuing the patent in the first place seems to contradict marijuana being a Schedule I drug, seeing that the schedule itself is meant for substances that are dangerous and not useful for medical purposes in any way. 

As time passes, cannabis research provides more and more peer-reviewed evidence that marijuana is effective in treating a vast array of medical issues, including cancer, glaucoma, multiple sclerosis, chronic pain, arthritis, asthma, insomnia, depression, and epilepsy. What’s more, it is also less expensive and less dangerous than many drugs currently used to treat many of these conditions. It makes sense that a patent for marijuana would be issued to create a better quality of life for people afflicted with any of these conditions. What does not make sense is why it is still a Schedule I drug. 

Why Is Cannabis Still So Illegal Despite This Patent?

The National Institute of Health (NIH) hires about 6,000 Ph.D. scientists to oversee all the studies in its institutions. If a notable discovery is made, the decision must be made about whether to file a patent. Patent no. 6,630,507 was granted as a result of research showing the possibility that parts of the cannabis plant, those that are non-psychoactive, are effective in the treatment of neurological diseases. Because relief from these diseases via the cannabis plant is possible without getting high from THC, the patent was granted.

The patent does not say there is proof that treatment using cannabinoids is effective. That would require laboratory purification and synthesis of the compound, not to mention loads of animal and human testing, plus being approved by the FDA once all that is done, like what has happened with Epidiolex.

In other words, the patent was granted because–at the time it was applied-for–there was a possibility that it could be effective, and worthy of further research. In the meantime, the government has kept its potential largely hidden from the public and classified as a Schedule I drug. 

Green in More Places Than One

That patent has a bit more complexity than just looking into the medical possibilities of certain parts of the cannabis plant, however. The government may have more than just public health in mind when this patent went through. There’s a lot of money to be made in the event that elements of the cannabis plant do provide effective medical treatments. In fact, the amount of money that certain firms could come into as a result of patent no. 6,630,507 is no small sum. This begs the question: who exactly is set to be making money off this deal?

Kannalife Sciences Inc. is a company based in New York. They obtained a license from the NIH in 2011 to use some of the patent’s technology. What they want to do is develop CBD-based medicines to treat hepatic encephalopathy (CTE), a form of brain damage. As such, Kannalife can now use the patented technology for research. In the event that they develop a successful drug, Kannalife CEO Dean Petkanas mentioned the government would get a huge percentage of sales that could result in six-figure royalties

If the government has known about these potential benefits of parts of the cannabis plant, why did they deny the rescheduling of marijuana in 2016? Keeping marijuana a Schedule I drug makes it harder for other research to be done, which benefits Kannalife and the US government financially. 

Before 2016, Kannalife was the only company with a license to a piece of the patent. That changed when GW Pharmaceuticals also got its own piece of the patent as it completed its new drug application for Epidolex. Epidolex is a drug developed using CBD to treat seizures. Upon approval, the drug could earn upwards of $2.2 billion a year. Seeing that the government will receive royalties from that as well, it raises questions about the real reasons marijuana has been kept a Schedule I drug. 

With the legalization across many US states in recent years, companies have been both applying for and getting approved for patents using cannabinoids like CBD to make medicine for a variety of medical conditions. In 2018, the US Patent and Trademark Office issued 39 patents which contained the words marijuana or cannabis in their summaries. In 2017, that number was 29, and in 2016, only 14. Those patents are for different uses of cannabinoids than patent no. 6,630,507, though still completely leaving out THC.

Patent no. 6,630,507 expires on April 21, 2019. After that, using the cannabinoids outlined in the patent will be fair game for everyone, though any drugs created will still have to be approved by the FDA.

A Case of Hypocrisy 

Even professionals like Gregory F. Wesner, a patent and trademark attorney, don’t deny the hypocrisy in patent no. 6,630,507. By classifying marijuana as a Schedule I drug, it means that all parts of the plant are deemed unsafe for consumption, according to the DEA and US government. Yet, the US government has a patent on synthetic cannabinoid drugs derived from marijuana, which are then being approved by the FDA. 

Legalizing marijuana nationally would dramatically change the distribution of profits from marijuana, as many people and companies would be filing for patents almost immediately. The low number of patents approved per year despite abundant research showing the medical benefits of the plant serves to show how stifled the industry is by keeping marijuana a Schedule I drug. This begs the question: why does the US government continues to keep marijuana a Schedule I drug? Companies like Kannalife and GW Pharmaceuticals would be up against competition instead of having the industry nearly all to themselves, which would would cut into both their own profit and the profit the government. Companies like Kannalife and GW Pharmaceuticals would be up against competition instead of having the industry nearly all to themselves, which would would cut into both their own profit and the profit the government. 

Could CBD Help Elderly Patients?

In recent years, CBD oil and other hemp products have been gaining popularity as an effective herbal supplement to treat a wide variety of issues. In fact, data on CBD user demographics show 40% of Americans are interested in trying CBD. However, one particular demographic could potentially benefit more from this now popular product. Elderly patients may be able to use CBD to improve many health problems associated with aging.

The Popularization Of Hemp

CBD as alternative medicine isn’t a particularly new phenomenon. Hemp has been used historically to treat a wide variety of conditions. However, the legalization of CBD hemp specifically has fueled an entirely new market of products. Usually, these are marketed towards younger generations as an herbal supplement, but CBD has been proven as an effective treatment in certain cases of severe epileptic disorders and other psychiatric issues. In cases where medical marijuana has been fully legalized outside of mere CBD products, there have been countless benefits for specific populations, particularly the elderly.

Psychological Benefits For The Elderly

Aging has many unwanted effects on the body, with some of the most severe including psychiatric disorders like dementia and Alzheimer’s. A whopping 64% of people aged 65 and older in nursing homes have Alzheimer’s disease or another form of dementia. But it’s possible that CBD products could be used to help patients cope. 

Studies are still being conducted, but with CBD’s impacts on the brain, there’s some evidence to show that those suffering from multiple types of psychiatric disorders could benefit from its use. This is especially true of legalized medical hemp products, as opposed to synthetic options; being able to draw from the full plant allows patients to access a wider variety of cannabinoids and terpenes while also reducing potential side effects.

The Limitations Of CBD

While it’s easy to get excited about CBD and hemp’s potential as a treatment for many of the issues associated with aging, it’s important to remember that the effects of hemp on the brain are still being studied. While its use as a treatment for certain conditions has already been scientifically proven, many attempting to market CBD will claim it can treat conditions that have yet to be supported by evidence. CBD, unfortunately, is not a cure-all. But it still has powerful treatment potential for many different diseases.

With CBD use continuing to rise across all demographics, it remains to be seen exactly what the long-term benefits will be. However, it is likely that aging and elderly populations will see many benefits from hemp’s potential as a psychiatric treatment. As estimates show that there will be about 14.1 million people aged 85 and above in the United States by 2040, these benefits can’t come soon enough. It’s now up to the research to confirm what the effects of CBD truly are.

CBD in cannabis could reduce psychosis risk from high strength skunk, study shows…

Alex Matthews-King Health Correspondent | INDEPENDENT

Buffer effect could point to a protective mechanism that may help ‘treat disorders like psychosis and addiction’

Cannabidiol (CBD), a chemical derived from the cannabis plant, can counteract the effects of high strength “skunk” strains and may help to reduce the risk of serious mental health conditions like psychosis, according to a new study. 

After using scans to study the effects of different strains of cannabis on the brain for the first time, the team from the University College London said boosting levels of CBD could act as a “buffer” to ill effects.


They found that strains with the same level of THC, the chemical which causes users to get “stoned”, but higher CBD caused less disruption to parts of the brain linked to addiction and psychosis.


Users also reported a reduction in feelings of being high and experts said this lent support to using high-CBD strains for medicinal uses.


“Over the last two decades, rates of addiction and psychosis linked to cannabis have been on the rise, while at the same time stronger strains of cannabis with more THC and less CBD have become increasingly common,” said Dr Matt Wall, lead author of the study which was published in the Journal of Psychopharmacology.

He added: “We have now found that CBD appears to buffer the user against some of the acute effects of THC on the brain.”

Cannabis contains hundreds of chemicals known as cannabinoids, with THC (tetrahydrocannabidiol) being the most abundant in modern strains followed by CBD.

In the UK, where recreational cannabis remains illegal and medicinal use in its infancy, the prevalence of skunk has been blamed for London having the highest rates of psychosis in Europe.


Meanwhile CBD oils are increasingly sold in health shops for an array of ailments despite limited evidence, thanks in part to decades of prohibition.

The UCL trial used MRI scans to study activation of different parts of the brain after using two strains, equivalent to a “skunk” strain with low CBD and a higher level.

It found that the low-CBD “skunk” strain disrupted signals from neurons in a region of the brain called the posterior cingulate and this led to users reporting feeling more stoned.

There was also interference in the network of neurons which underpin emotional and sensory information, known as the salience networks.

Disrupting these areas has been linked to addiction and psychosis, but CBD helped alleviate this and could point to a protective or medicinal use.

“If CBD can restore disruption to the salience network, this could be a neuroprotective mechanism to explain its potential to treat disorders of salience such as psychosis and addiction,” said Professor Val Curran.

Hemp Vs. CBD – What’s the difference between hemp and CBD crops? And what’s better, isolate or full-spectrum CBD?

Hemp for Victory

North America is bustling with hemp crops this growing season, and there’s talk of more and more planting in the seasons to come. It appears that the majority of more recent hemp-growing efforts are for the production of CBD (cannabidiol), the highly sought-after medicinal compound found in cannabis.

CBD is used for a wide range of applications and has a variety of benefits for both people and animals. CBD provides physical and mental stimulation, although it’s not considered to be a psychoactive substance because it doesn’t produce the noteworthy buzz that people associate with recreational cannabis use. CBD is used to treat pain, promote healing, reduce anxiety, stimulate appetite and encourage sleep. Some research shows that the human body produces its own substance that is biologically very much like the CBD that comes from cannabis. In fact, there are receptors in the human brain that are very specific to CBD. Preliminary research even suggests that CBD can be a disease-fighting substance, even for use against cancer.

While CBD is just one of the many beneficial substances produced by the cannabis plant, including THC and terpenes, it’s an area of great focus that continues to grow from consumer, research and industrial perspectives.

In the United Sates, CBD is relatively unregulated (especially when compared with THC), which has resulted in its widespread adoption and acceptance as it is increasingly included in a wide range of consumer products.

CBD can be vaped, smoked, eaten or taken topically (e.g., in skin creams), with each delivery method having its own benefits depending on the desired end result. If you name a type of product, chances are there is a CBD-infused version now available. If not, it’s not very far off.

Without a doubt, CBD is widely accepted as a beneficial and therapeutic substance, and we are likely to see more and more of it in everyday applications.

CBD Isolate

The majority of consumers who are interested in CBD tend to associate it with the hemp plant—marijuana’s cousin, if you will. A lot of the time this is accurate—many CBD-infused products are formulated with CBD isolates, which are typically derived from industrial hemp crops.


At present, a significant percentage of CBD isolates coming into North America are imported legally or otherwise from China. There have been a number of concerns raised by those in the know regarding importation from China, citing poor or even dangerous agricultural practices used to produce hemp crops as parent material for CBD isolates.

CBD isolate is an accurate name for this substance—it is an isolated component from a wide range of naturally occurring substances in cannabis plants, typically hemp. CBD isolate is usually a white, crystalline powder with no strong discernible odor or flavor. From a CBD-infused-product manufacturer’s perspective, it’s easy to work with to create products that are consistent in effect, flavor, smell and appearance.

From a consumer point of view, is CBD isolate from hemp the best choice as an ingredient to deliver the therapeutic effects desired? The short answer is likely not.

Why Full Spectrum?

The best and briefest answer to why full-spectrum cannabinoid extracts rich in CBD are often superior when it comes to the effects and benefits we desire has roots in what has been coined the “entourage effect.” Basically, full-spectrum CBD extracts contain other important substances such as aromatic compounds and traces of other cannabinoids found naturally in cannabis plants that work synergistically with the key ingredient, CBD, to amplify and improve the benefits we seek.

Compare powdered orange juice with fresh-squeezed juice. Both will supply you with your necessary daily dose of vitamin C; however, fresh-squeezed juice will also provide your body with other important substances like enzymes, naturally occurring sugars, calcium and more, all working together to improve your health more than vitamin C can do alone. Arguably, the natural source is easier for your body to absorb, too, as it is supplied with other healthy substances.

A simple observation many consumers have made when it comes to products containing CBD is that they feel more of the desired effects, like pain relief or relaxation, when the product they take—comparing milligram to milligram of CBD—has been derived from full-spectrum sources.

Take the very popular CBD gummy bear for example—which, by the way, was Google’s No. 3 food search in 2018. Given the same listed amount of CBD—for example, each bear is tested to have 20 milligrams of CBD—the majority of consumers find they have to eat more of the isolate-derived bears to begin to achieve the same benefits as when eating the full-spectrum bears.

Again, this circles back to the entourage effect that cannabinoids are thought to have. Consumers prefer a full-spectrum cocktail of naturally occurring ingredients to a one-dimensional synthesized single ingredient.

Live CBD Resin Extracts

A full-spectrum dose of CBD won’t necessarily get you high. It’s entirely possible to create natural full-spectrum extracts or even smokable flowers that are very low in THC but contain very high levels of CBD—for example, 20:1 ratios of CBDA to THCA—without removing the other beneficial substances like the aromatic compounds, including terpenes (or terps).

Live CBD resin extracts are a great example of this, with the end result being a highly concentrated full-spectrum CBD extract that can be added to a wide array of consumer product goods or even dabbed or vaped in its raw state. A live CBD resin extract from quality cannabis appears golden and transparent—you can read newsprint through it.

What it all really boils down to in obtaining highly beneficial and naturally occurring CBD extracts is plant genetics, i.e., cannabis plants that naturally produce very low THC levels while containing very high CBD levels and beneficial terpene profiles for therapeutic purposes where no “buzz” or intoxicating effects are sought.

What to Grow?

The majority of us are taught that hemp is the version of cannabis that fits that criteria—and this is where our CBD extracts for infusion in a variety of products should come from.

This isn’t entirely accurate—or even beneficial for either the consumer or the environment.

Here’s why.

Historically, hemp has been cultivated in North America for food and fiber, e.g., stalks for rope or textiles. Hemp seeds are harvested for their nutritional oil and protein content and not for high levels of CBD. Hemp tends to be a low-potency cannabis-plant variant that genetically has a higher ratio of CBD to THC, with not a whole lot of either compared with modern recreational-use cannabis genetics.

Hemp was not bred for its cannabinoid content, terpene profile, etc.—all the stuff that people who take CBD for its nutraceutical value are seeking. Hemp was bred and selected to be a hardy plant that grows easily and yields thick cellulose- and lignin-rich stems and stalks along with protein- and oil-rich seeds. Hemp is an extremely useful agricultural plant and makes for excellent fiber and food—however, don’t make the mistake of thinking that it’s the best source of therapeutic substances like CBD.

CBD from Hemp?

At present, regulations for growing hemp crops in North America make it much easier to obtain a license for legal cultivation, especially on any industrial scale when compared with growing marijuana, although both are in fact members of the cannabis plant family. That’s why a lot of people interested in producing CBD are cultivating cannabis as hemp, even though they may not desire to harvest the crop for food or fiber (which is what hemp was bred and selected for).

Regulations vary in North America from country to country, state to state and province to province to greater or lesser extents.

The majority of these hemp crops being grown for their CBD content at present day have tight restrictions placed on seed sourcing. By regulation, these approved hemp-seed genetics have very low THC potency, which usually means low CBD yields too.

This has created a situation where would-be CBD field-crop producers are forced by legislation and the law to select and buy approved hemp varieties. Most of these varieties are not likely to produce over 6 percent CBD. In fact, most will be closer to 3 percent while keeping with THC values of 0.3 percent or less (as is often mandated).

CBD from Drug Cultivars

Now let’s take modern CBD drug cultivar genetics and compare.

CBD drug cultivars are strains of cannabis with genetics that more closely resemble modern high-THC plant types—all your favorite high-potency strains. Unlike hemp, these plants do not grow very thick stems in a pole-like pattern. Drug cultivars are squat and more widely branched. The most important thing here is that the drug cultivars have been bred and selected with a large emphasis on resin production rather than on thick stocks or hardy seeds as with true hemp genetics.

CBD drug cultivars have lots of trichomes and pump out lots of resin. Really, one of the only differences CBD drug cultivars have compared with high-potency recreational cannabis strains is that the THC-to-CBD ratio is for all intents and purposes reversed.

There are feminized seed sources available that are capable of producing over 20 percent CBD consistently and that also carry a beneficial terpene profile (for the entourage effect), making them absolutely ideal for full-spectrum CBD-rich extracts. However, some of these genetics may produce 0.3-0.7 percent THC.

While that THC level is not enough to create a high, it is enough for the seeds not to meet the present-day criteria as hemp genetics and therefore get lumped into the same category as traditional marijuana cultivars.

Although these strains yield a 500-1,000 percent increase in CBD compared with approved hemp varieties, they are unavailable to legal producers because of a few decimal points’ difference in THC (which in reality is no real difference).

So, to sum it up in the context of hemp crops versus a true CBD crop, a producer has to grow five to 10 times the acreage to achieve the same end yield of CBD, which is not likely to be as high a level of quality—simply to satisfy current regulatory standards. To reiterate, the 20 percent or greater CBD strains (versus 3-6 percent, at best, with hemp) are not producing enough THC to get anybody high, but they are explicitly forbidden by most hemp-growing regulatory bodies.

In short, that’s nuts. That’s five to 10 times the resources and expenses to achieve a lesser end result. And to what end? Who really benefits from this?

The Future of CBD

Improved regulations for growers need to address CBD production specifically. Lumping CBD production and hemp into the same crop category, especially for mandatory seed sourcing, seems like a mistake. Other countries have created workable allowances for high-CBD strains with very low THC levels that work for farmers and CBD producers—for example, 1 percent THC or less is permissible in Colombia.

Undeniably, the increase in hemp-farming licenses issued recently is a positive step forward in renewing the value of hemp production in North America. However, due to modern breeding and selection, crops for CBD may not really be “hemp” anymore. It’s like comparing the heavily seeded brick weed of the ’70s with what is presently harvested in a modern cultivation facility; the two products are simply worlds apart.

Following regulations is not optional on an industrial scale, and having the voice of the growing community heard in public forums where decisions are influenced or made surrounding cannabis crop production is as important as it ever has been. Facts are difficult to debate, especially when resources like fresh water for crops are becoming increasingly scarce in important growing regions—growers need policies and regulations that are based on reason, as does the public, which supports these practices and regulatory bodies as consumers.

In some parts of the world like Europe, hemp production is a well-established institution, and Canada is also becoming an established hemp producer since improved legislation for field-hemp farmers has been rolled out over the last two decades.

In comparison with the hemp-production industry, the global CBD industry is in its infancy, with massive potential for use in a wide array of products the world over.

It is important for people to understand that while hemp and CBD crops may be similar in some aspects—both are from the cannabis family, after all—they are in fact very different plants when it comes to desired genetics. Educated and informed consumers can help influence legislation and regulations that better fit CBD producers—often, the most powerful vote we make is when we spend our money.

Just like the food you eat, it’s good to know where the CBD you take is coming from or sourced. And also like the food you eat, sometimes the best choice can come right out of your own garden. Choose wisely.

Thousands of UK Patients will be given Cannabis in Groundbreaking Study.

This article was published on: by: Caitlin Donohue 

The UK’s first large-scale cannabis study and biggest marijuana health investigation in European history has been announced, raising hopes that many of the country’s health professionals will finally be swayed on the efficacy of the drug for use in treating seven different health conditions.

Substance reform organization Drug Science is administering the investigation, which is called Project TWENTY21. Neuropsychopharmacologist David Nutt, previously of the University of Bristol, will be in charge of the study, which will examine cannabis’ effects on chronic pain, multiple sclerosis, epilepsy, post-traumatic stress disorder, Tourette’s syndrome, anxiety disorder, and substance abuse.

Earlier this year, media reports found that many UK hospitals were refusing to recommend medical cannabis based on “the risk of serious side effects.” Pain management clinic staff members were quoted saying, “We would welcome high-quality studies into the use of cannabis-based medicinal products for pain treatment.”

All the more reason to be excited about the Project TWENTY21 study, which will fund medical cannabis treatment for 20,000 patients by the end of 2021. The project has previously announced that it will be doing work in the fields of prison population harm reduction and the use of cannabis as a counterweight to drug addiction.

“I believe cannabis is going to be the most important innovation in medicine for the rest of my life,” commented Nutt. “There are children who have died in this country in the last couple of years because they haven’t had access to cannabis. It’s outrageous, it’s unnecessary and we want to rectify it.”

Although Health England has been extremely slow to endorse cannabis as medication, Project TWENTY21 has the co-sign of the British Pain Society, United Patients Alliance, and the Royal College of Psychiatrists.

“The College welcomes this pilot project which it hopes will make an important contribution towards addressing the paucity of evidence for the use of cannabis-based medicinal products,” commented the institution’s president Wendy Burn.

“We hope that this project, along with other research such as more much-needed [randomized] control trials, will continue to build the evidence on [cannabis-based medicinal products],” she continued.

Cannabis in the UK

It’s not the only cannabis study being conducted in the UK. University of Westminster researchers recently released the results of an investigation that concluded CBD could be a useful tool in the fight against antibiotics resistance, which currently costs the lives of some 5,000 people in England every year, according to the country’s public health agency.

Medical cannabis has been legal in the UK since October 2018. But the issue of medical marijuana has been of much debate in the country, its urgency exacerbated by the mounting problem of opioid addiction.

A prime motivator in the case of Great Britain has been the drug’s efficacy when it comes to sick kids. Young people like eight-year-old epilepsy patient Alfie Dingley and five-year-old Indie-Rose Montgomery, whose cannabis oil to treat her seizures was confiscated at London Stansted Airport in July, have shown the public how the issue is affecting fellow Brits.

5 Key Benefits of CBD Oil

We all wish to live uncomplicated, easy-going, and fulfilling lives. However, not everything in life can run as smoothly as we expect. Every aspect of our lives has expectations and responsibilities. And, sometimes the stress of attaining those expectations can become too much for most people to handle. And what it takes to get through such days is a little help from friends, family, or sometimes a supplement like Cannabidiol.


Generations across the world have discovered different ways to make their bodies and minds healthier. And, one of the most preferred pick me ups across the world was hemp. However, hundreds of years later, thanks to the development of technology, CBD OR Cannabidiol was discovered. And the proof of its popularity lies in its increase in sales. By 2022, the sales of CBD are projected to increase to $1.8 billion. This will see the use of cannabidiol become even more popular in different parts of the world.


So, What Makes CBD Popular?


The first aspect is its origin. Cannabidiol is a form of a chemical compound derived from the plant cannabis. Unlike cannabis, CBD is not psychoactive— this means it will not impact or impair users’ mental state of mind. The second aspect that makes CDB oil quite popular is its numerous benefits. Some of the benefits you can expect from the use of CBD oil include:


1. Relief from Inflammation and Chronic Pain


Back in 2900 B.C., marijuana was used to help in the treatment of chronic pain. Centuries later, scientists began to discover the essential aspects of marijuana that help in alleviating pain. One of those components includes cannabidiol. CBD oil for pain has become quite popular and has been known to work more efficiently compared to pharmaceutical drugs.


2. Could Help Reduce Anxiety


In the US alone, approximately 6% of the population suffers from depression, while 18% suffer from anxiety. And to help reduce anxiety and depression, more and more people are starting to turn to CBD oil for anxiety. Unlike pharmaceutical drugs, CBD oil has no effects, and this makes it quite easy to use it regularly.


The use of CBD oil has also shown significant promise in treating other mental disorders. It has also been used to treat insomnia in children suffering from post-traumatic stress. Also, several studies show that the ability of CBD to act as an antidepressant is due to its capability to regulate social and mood behavior.


3. Reduces Stress


Our everyday life is full of stress. And a majority of us cannot cope with it all the time. Trying to balance between your personal and emotional life can be quite impossible. Using full spectrum CBD oil can help you relax and disconnect from the world for a few hours. CBD gives you the ability to clear your mind, relieve stress, and settle your heart rate.


This allows you to regain control, focus, and get your life back on track. Life is unpredictable but having something that can help you disconnect can make any situation manageable.


4. Helps Fight Addictions


According to the Journal of Substance Abuse published in 2015, CBD oil has helped people overcome their addictions by helping them with their withdrawal symptoms. In this report, 14 studies were analyzed by the Journal, and each one determined that CBD oil has a therapeutic effect on individuals with a psycho-stimulant, opioid, and cocaine addictions.


The studies also concluded that it can also be used to treat individuals with tobacco and cannabis addiction. The reason for this is because of its THC’s effect. This effect makes it easy to withdraw from drug cravings.


5. May Help Reduce Acne


Acne is a skin condition and is caused by numerous factors like bacteria, genetics, and underlying inflammation. However, the use of CBD oil does help reduce acne because of its anti-inflammatory effects. And the more you use it, the better your skin becomes.


So, if you are looking for a natural way to relieve stress, get rid of pain, or reduce acne, you do not have to look any further, THC free hemp oil will do the trick.

Here’s Why You Should Use CBD Oil

full spectrum cbd oilCannabidiol (CBD) is a complex compound obtained from the marijuana plant. The CBD isolate and full-spectrum CBD oil are the two main types of CBD. Full spectrum CBD oil is one of many compounds extracted from the non-psychoactive strains of the cannabis plant.

Tetrahydrocannabinol (THC) is the psychoactive chemical substance derived from the hemp plant and is thought to cause hypnosis. Full spectrum CBD is a whole-plant CBD due to its extraction from cannabis together with all other chemical substances such as cannabinoids, terpenes, vitamins. CBD vape pens and CBD tinctures are a few ways of consuming full-spectrum CBD oil.

Since the cannabis species involved in making full-spectrum hemp oil are high in cannabidiol, there is minimal effect on your mental state, mood, or cognition. Full Spectrum CBD oil is safe for people of all ages, and it’s legal to purchase in all 50 states. Below is a list of benefits associated with CBD oil.

Relieves Pain and Inflammation

In the past, the marijuana plant was used to treat chronic pain. Today, scientists have been able to isolate and study the parts of the marijuana plant that are responsible for pain relief. According to a study conducted in 2018, the majority of the main compounds in full spectrum CBD oil and other cannabinoids relieve different types of pain.

The THC free CBD oil reduces pain by impacting the endocannabinoid receptor activity in the brain. The neurotransmitters are responsible for regulating responses related to agony, appetite, and the need for sleep. CBD oil for pain contains powerful antioxidant properties, which are vital for overall immune health.

Helps Reduce Anxiety and Depression

Anxiety and depression are among the most common mental health disorders that have detrimental impacts on personal well-being. Given that most of the over-the-counter drugs have side effects, most people opt for the natural approach. Using CBD oil for anxiety can positively impact the brain’s receptors for serotonin, a neurotransmitter that regulates mood and social behavior.

CBD oil is a widely available treatment option for anxiety sufferers with zero side effects. Studies have found that full-spectrum CBD oil is effective in relieving insomnia, social anxiety symptoms, increased agitation, and PTSD. Additionally, Full spectrum hemp oil has demonstrated the ability to mitigate anxiety disorders.

CBD Aids in Fighting Cancer

Recent studies show that full-spectrum CBD oil may help in resisting the production of cancer cells. It decreases the ability of cancer cells to grow and prevents cancer cell migration to other parts of the body and organs. Along with CBD’s proven interactions with the body’s endocannabinoid system, CBD can help with cancer treatments as well as enabling a sense of balance throughout various body systems.

Through the pain-alleviating properties of the THC free hemp oil, patients can feel better after chemotherapy. CBD may also help reduce chemotherapy-induced nausea and vomiting, which are among the most common side effects of cancer treatment. The use of CBD oil in the treatment of cancer shows promise due to its low toxicity, non-psychoactive side effects, and its noninvasive nature.

CBD for Alzheimer’s Disease

CBD can prevent the development of a social recognition deficit among Alzheimer patients. Full-spectrum hemp oil could help people in the early stages of Alzheimer’s retain their ability to recognize familiar faces, and in turn, slow the progression of the disease. Recent research shows that full spectrum CBD oil was able to reverse cognitive deficits and show neuroprotective properties in the brain.

The study is the first to show that full spectrum hemp oil zero THC may be an Alzheimer preventive treatment measure, particularly in social withdrawal and facial recognition. Multiple treatments designed to reduce the effects of the disorder exist, but none can stop the physical momentum of Alzheimer’s in its progression.

Full spectrum CBD oil has proven to be a treatment of various ailments. CBD oil provides a safe, powerful natural remedy for many health issues. With the ongoing research, there are bound to be more therapeutic uses for the full-spectrum CBD oil zero THC in the coming days.

Scroll to top